Owens & Minor (NYSE:OMI) PT Raised to $28.00 at Citigroup

Owens & Minor (NYSE:OMI) had its target price boosted by Citigroup from $24.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s price target points to a potential upside of 16.76% from the company’s current price.

Several other research analysts have also weighed in on the stock. StockNews.com raised shares of Owens & Minor from a “hold” rating to a “buy” rating in a report on Wednesday, February 21st. Leerink Partnrs restated a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. SVB Leerink assumed coverage on Owens & Minor in a report on Monday, February 26th. They set a “market perform” rating and a $24.00 target price on the stock. Robert W. Baird boosted their price target on Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a report on Wednesday, April 10th. Finally, Barclays raised their price objective on Owens & Minor from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $23.86.

Owens & Minor Stock Down 3.1 %

Shares of Owens & Minor stock opened at $23.98 on Tuesday. Owens & Minor has a 1-year low of $13.34 and a 1-year high of $28.35. The company has a market capitalization of $1.84 billion, a PE ratio of -44.46, a P/E/G ratio of 0.80 and a beta of 0.43. The company has a debt-to-equity ratio of 2.05, a current ratio of 1.11 and a quick ratio of 0.52. The business has a 50-day moving average of $25.39 and a 200-day moving average of $21.33.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.03. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The firm had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.67 billion. During the same quarter last year, the firm earned $0.28 EPS. Owens & Minor’s quarterly revenue was up 4.1% on a year-over-year basis. As a group, equities analysts forecast that Owens & Minor will post 1.54 EPS for the current fiscal year.

Insider Buying and Selling

In other Owens & Minor news, SVP Jonathan A. Leon sold 5,000 shares of the firm’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the sale, the senior vice president now directly owns 84,673 shares in the company, valued at $2,103,277.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares in the company, valued at approximately $1,791,350. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Jonathan A. Leon sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the sale, the senior vice president now owns 84,673 shares in the company, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. 2.62% of the stock is owned by company insiders.

Hedge Funds Weigh In On Owens & Minor

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OMI. Riverview Trust Co acquired a new position in Owens & Minor during the 1st quarter worth $25,000. DekaBank Deutsche Girozentrale acquired a new stake in Owens & Minor in the third quarter worth about $29,000. Quest Partners LLC bought a new position in Owens & Minor in the 4th quarter valued at about $41,000. Hexagon Capital Partners LLC increased its stake in Owens & Minor by 1,240.2% during the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after buying an additional 1,451 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Owens & Minor by 52.1% during the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock worth $46,000 after buying an additional 563 shares in the last quarter. 98.04% of the stock is owned by institutional investors.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.